Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation

Biochemical and Biophysical Research Communications

Volumn 327, Issue 4, 2005, Pages 1083-1087

  Liao, Yulin ^a   Asakura, Masanori ^a   Takashima, Seiji ^a   Kato, Hisakazu ^a   Asano, Yoshihiro ^a   Shintani, Yasunori ^a   Minamino, Tetsuo ^a   Tomoike, Hitonobu ^b   Hori, Masatsugu ^a   Kitakaze, Masafumi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Calcium channel blocker; Cardiomyocyte; Epidermal growth factor; Hypertrophy; Mouse; Phosphorylation

Indexed keywords

ADRENALIN; AMLODIPINE; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT;

AMLODIPINE; ANIMALS; CARDIOMEGALY; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; EPINEPHRINE; HEPARIN; MALE; MICE; MYOCARDIUM; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BIOSYNTHESIS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

ANIMALIA;

EID: 19944433413     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.112     Document Type: Article

References (22)

1. J. Muntwyler, and F. Follath Calcium channel blockers in treatment of hypertension Prog. Cardiovasc. Dis. 44 2001 207 216
2. M. Asakura, M. Kitakaze, S. Takashima, Y. Liao, F. Ishikura, T. Yoshinaka, H. Ohmoto, K. Node, K. Yoshino, H. Ishiguro, H. Asanuma, S. Sanada, Y. Matsumura, H. Takeda, S. Beppu, M. Tada, M. Hori, and S. Higashiyama Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy Nat. Med. 8 2002 35 40
3. 2+ channels involved in ET-1-induced transactivation of EGF receptors Am. J. Physiol. Heart Circ. Physiol. 283 2002 H2671 H2675
4. L.B. Rosen, and M.E. Greenberg Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels Proc. Natl. Acad. Sci. USA 93 1996 1113 1118
5. 2+ entry in mouse mammary epithelial cells Cell Biochem. Funct. 19 2001 213 219
6. Y. Liao, S. Takashima, Y. Asano, M. Asakura, A. Ogai, Y. Shintani, T. Minamino, H. Asanuma, S. Sanada, J. Kim, H. Ogita, H. Tomoike, M. Hori, and M. Kitakaze Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model Circ. Res. 93 2003 759 766
7. S. Tokumaru, S. Higashiyama, T. Endo, T. Nakagawa, J.I. Miyagawa, K. Yamamori, Y. Hanakawa, H. Ohmoto, K. Yoshino, Y. Shirakata, Y. Matsuzawa, K. Hashimoto, and N. Taniguchi Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing J. Cell Biol. 151 2000 209 220
8. Y. Liao, F. Ishikura, S. Beppu, M. Asakura, S. Takashima, H. Asanuma, S. Sanada, J. Kim, H. Ogita, T. Kuzuya, K. Node, M. Kitakaze, and M. Hori Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation Am. J. Physiol. Heart Circ. Physiol. 282 2002 H1703 H1708
9. C. Pignier, I. Levan-Petit, C. Ancey, and D. Potreau Alpha-adrenoceptor stimulation induces hypertrophy and increases L-type calcium current density in neonatal rat ventricular cardiomyocytes in culture Receptors Channels 7 2000 173 187
10. R. Passier, H. Zeng, N. Frey, F.J. Naya, R.L. Nicol, T.A. McKinsey, P. Overbeek, J.A. Richardson, S.R. Grant, and E.N. Olson CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo J. Clin. Invest. 105 2000 1395 1406
11. S. Minamisawa, M. Hoshijima, G. Chu, C.A. Ward, K. Frank, Y. Gu, M.E. Martone, Y. Wang, J. Ross Jr., E.G. Kranias, W.R. Giles, and K.R. Chien Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy Cell 99 1999 313 322
12. E. Zwick, H. Daub, N. Aoki, Y. Yamaguchi-Aoki, I. Tinhofer, K. Maly, and A. Ullrich Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling J. Biol. Chem. 272 1997 24767 24770
13. B.H. Shah, M.P. Farshori, A. Jambusaria, and K.J. Catt Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation J. Biol. Chem. 278 2003 19118 19126
14. Q. Zhang, S.M. Thomas, S. Xi, T.E. Smithgall, J.M. Siegfried, J. Kamens, W.E. Gooding, and J.R. Grandis SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells Cancer Res. 64 2004 6166 6173
15. H. Schottelndreier, B.V. Potter, G.W. Mayr, and A.H. Guse Mechanisms involved in alpha6beta1-integrin-mediated Ca(2+) signalling Cell. Signal. 13 2001 895 899
16. K.R. Waitkus-Edwards, L.A. Martinez-Lemus, X. Wu, J.P. Trzeciakowski, M.J. Davis, G.E. Davis, and G.A. Meininger alpha(4)beta(1) Integrin activation of L-type calcium channels in vascular smooth muscle causes arteriole vasoconstriction Circ. Res. 90 2002 473 480
17. X. Wu, G.E. Davis, G.A. Meininger, E. Wilson, and M.J. Davis Regulation of the L-type calcium channel by alpha 5beta 1 integrin requires signaling between focal adhesion proteins J. Biol. Chem. 276 2001 30285 30292
18. Y. Zou, A. Yao, W. Zhu, S. Kudoh, Y. Hiroi, M. Shimoyama, H. Uozumi, O. Kohmoto, T. Takahashi, F. Shibasaki, R. Nagai, Y. Yazaki, and I. Komuro Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin Circulation 104 2001 102 108
19. 2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats Hypertension 41 2003 963 967
20. M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuberg, D. Frid, J.H. Wertheimer, A.B. Cropp, and D.L. DeMets Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group N. Engl. J. Med. 335 1996 1107 1114
21. R.A. Kloner, M. Weinberger, J.L. Pool, S.G. Chrysant, R. Prasad, S.M. Harris, T.M. Zyczynski, N.K. Leidy, and E.L. Michelson Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of candesartan and amlodipine for safety, tolerability and efficacy (CASTLE) study investigators Am. J. Cardiol. 87 2001 727 731
22. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA 288 (2002) 2981-2997